Growing community of inventors

Destelbergen, Belgium

Petra Blom

Average Co-Inventor Count = 3.02

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

Petra BlomJan Hoflack (4 patents)Petra BlomDirk Leysen (2 patents)Petra BlomSandro Boland (2 patents)Petra BlomNadzeya Kaval (2 patents)Petra BlomOlivier Lavergne (1 patent)Petra BlomOlivier Defert (1 patent)Petra BlomPascal Benderitter (1 patent)Petra BlomSylvie Gomez (1 patent)Petra BlomOliver Defert (1 patent)Petra BlomPetra Blom (6 patents)Jan HoflackJan Hoflack (4 patents)Dirk LeysenDirk Leysen (10 patents)Sandro BolandSandro Boland (10 patents)Nadzeya KavalNadzeya Kaval (2 patents)Olivier LavergneOlivier Lavergne (18 patents)Olivier DefertOlivier Defert (9 patents)Pascal BenderitterPascal Benderitter (1 patent)Sylvie GomezSylvie Gomez (1 patent)Oliver DefertOliver Defert (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Oncodesign Sa (3 from 7 patents)

2. Ipsen Pharma S.a.s. (2 from 108 patents)

3. Amakem Nv (2 from 8 patents)


6 patents:

1. 10676486 - Macrocyclic RIP2 kinase inhibitors

2. 10377772 - Macrocyclic LRRK2 kinase inhibitors

3. 9370520 - Macrocyclic LRRK2 kinase inhibitors

4. 9096609 - Macrocyclic LRRK2 kinase inhibitors

5. 8912209 - Rock inhibitors

6. 8815873 - Heterocyclic amides as rock inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/1/2026
Loading…